When.com Web Search

  1. Ads

    related to: latest treatment for uterine fibroids

Search results

  1. Results From The WOW.Com Content Network
  2. There is help for women with uterine fibroids - AOL

    www.aol.com/help-women-uterine-fibroids...

    Treating uterine fibroids without hysterectomy

  3. Woman has uterine fibroids removed that equaled the size of a ...

    www.aol.com/news/woman-uterine-fibroids-removed...

    Erica Chidi, co-founder and CEO of Loom, a women's health education platform, is making her private health journey -- a six-year battle with uterine fibroids -- public, she said, in hopes of ...

  4. Gynesonics Announces New York Medicaid Coverage for CPT Code ...

    lite.aol.com/tech/story/0022/20241217/9320094.htm

    The code encompasses the Sonata ® Procedure, an innovative, incision-free treatment for symptomatic uterine fibroids that leverages Gynesonics’ proprietary Radiofrequency (RF) energy technology. Uterine fibroids affect up to 80% of women by the age of 50 and can cause debilitating symptoms, including heavy menstrual bleeding, pelvic pain ...

  5. Sonalleve MR-HIFU - Wikipedia

    en.wikipedia.org/wiki/Sonalleve_MR-HIFU

    Sonalleve MR-HIFU is a medical system developed by Philips Healthcare for the treatment of uterine fibroids without surgery. The system uses non-invasive high-intensity focused ultrasound (HIFU) guided by magnetic resonance (MR), hence the acronym MR-HIFU. The procedure involves volumetric heating of fibroids with real-time feedback. [1]

  6. Uterine fibroid - Wikipedia

    en.wikipedia.org/wiki/Uterine_fibroid

    Uterine fibroids, also known as uterine leiomyomas, fibromyoma or fibroids, are benign smooth muscle tumors of the uterus, part of the female reproductive system. [1] Most people [ note 1 ] with fibroids have no symptoms while others may have painful or heavy periods . [ 1 ]

  7. Linzagolix - Wikipedia

    en.wikipedia.org/wiki/Linzagolix

    Linzagolix, sold under the brand name Yselty, is a medication used in the treatment of uterine fibroids. [1] [5] Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) developed by Kissei Pharmaceutical and ObsEva.